2020
DOI: 10.1186/s40644-020-00324-z
|View full text |Cite
|
Sign up to set email alerts
|

Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation

Abstract: Various inflammatory abnormalities of the pancreas can mimic pancreatic ductal adenocarcinoma (PDAC) at cross-sectional imaging. Misdiagnosis of PDAC at imaging may lead to unnecessary surgery. On the other hand, chronic pancreatitis (CP) bears a greater risk of developing PDAC during the course of the disease. Thus, differentiation between mass-forming chronic pancreatitis (MFCP) and PDAC is important to avoid unnecessary surgery and not to delay surgery of synchronous PDAC in CP. Imaging features … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
29
0
4

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(47 citation statements)
references
References 48 publications
0
29
0
4
Order By: Relevance
“…The presence of (pseudo)cysts and parenchymal or intraductal calcifications may suggest an inflammatory cause, although these findings can also sometimes be found in intraductal papillary mucinous neoplasms, especially with main duct involvement[ 39 , 42 ]. Peripheral displacement of calcifications can be seen in patients with a malignant mass in the background of CP[ 43 ]. Another imaging feature that can be used to differentiate between malignancy and inflammation is the extent of ductal dilation and parenchymal atrophy, expressed by the pancreatic duct-to-parenchyma ratio.…”
Section: Diagnostics: Pancreatitis or Pancreatic Cancer?mentioning
confidence: 99%
“…The presence of (pseudo)cysts and parenchymal or intraductal calcifications may suggest an inflammatory cause, although these findings can also sometimes be found in intraductal papillary mucinous neoplasms, especially with main duct involvement[ 39 , 42 ]. Peripheral displacement of calcifications can be seen in patients with a malignant mass in the background of CP[ 43 ]. Another imaging feature that can be used to differentiate between malignancy and inflammation is the extent of ductal dilation and parenchymal atrophy, expressed by the pancreatic duct-to-parenchyma ratio.…”
Section: Diagnostics: Pancreatitis or Pancreatic Cancer?mentioning
confidence: 99%
“…Histologisch [6]. Zusätzlich liefert die Messung des "standard uptake value" (SUV) ebenso Hinweise zur Differenzialdiagnose, da die fokale AIP geringere SUV-Werte als das Pankreaskarzinom aufweist [23].…”
Section: Autoimmunpankreatitisunclassified
“…Eine Verlagerung bzw. Verdrängung der parenchymalen Verkalkungen in Zusammenhang mit einer neu aufgetretenen fokalen Weichteilmasse bei einer diffus verkalkten CP sollte den Verdacht auf ein Pankreaskarzinom bei CP erhärten [23].…”
Section: Introductionunclassified
“…A variety of benign pancreatic lesions may grossly appear intra-operatively as well-demarcated zone of parenchymal fibrosis and retention cysts as a result of chronic pancreatitis. Other benign lesions include inflammatory masses and pseudotumors, lymphoepithelial and epidermoid cysts and pancreatic hamartomas, hemangiomas and lymphangiomas (5)(6)(7)(8) . These benign diseases may be designated as pancreatic tumor-like lesions or pseudotumors (6,8,9) .…”
Section: Introductionmentioning
confidence: 99%